Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
Clinical trial NCT02376010 · COMPLETED
Trial details
- NCT number
- NCT02376010
- Sponsor
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-02
- Primary completion
- 2018-04-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.